City
Epaper

Kerala logs 5,023 Covid case, TPR at 8.15%

By IANS | Updated: February 23, 2022 18:55 IST

Thiruvananthapuram, Feb 23 Kerala continues to breathe easy as the daily Covid tally and the test positivity rate ...

Open in App

Thiruvananthapuram, Feb 23 Kerala continues to breathe easy as the daily Covid tally and the test positivity rate (TPR) continue to fall, with the state seeing 5,023 new cases on Wednesday and TPR was 8.15 per cent, Health Minister Veena George said in a statement.

While there were 11,077 recoveries, the state has 47,354 active cases, of which 6.6 per cent were in hospitals.

Another 13 Covid deaths were reported, taking the total death tally to 64,591.

Of the above 18-year-olds, 100 per cent (2.69 crore) have had one dose, of which 86 per cent (2.30 crore) have taken both, and in the 15-18 years group, 76 per cent (11.73 lakh) have been given one dose, while 29 per cent (4.41 lakh) have now received their second dose also.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Vascular resistanceVeena george
Open in App

Related Stories

NationalKerala Shocker: Scissors Found Inside Woman’s Abdomen 5-Years After Surgery, Health Minister Promises Strict Action

NationalSecond Mpox Case Confirmed in India; After Kerala Man Tests Positive For Virus

NationalNipah Virus: 13 High-Risk Contacts Test Negative in Malappuram, Says Kerala Health Minister Veena George

NationalKolkata Doctor Rape-Murder Case: Kerala Govt Orders Space Audit in Medical Colleges To Ensure Employee Safety

NationalThiruvananthapuram: Veena George Issues Warning Amid Rise In Brain Eating Disease In Kerala

Health Realted Stories

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns

HealthIndia’s millet push receives dual boost at technology and grassroots levels